Business
Johnson & Johnson single-dose vaccine shown to be effective against COVID-19 – ABC News
The single-shot option is not as strong as some of its two-shot rivals, however it could be potentially helpful for a world in dire need of more doses.
Johnson & Johnson’s (J&J) vaccine candidate appears to protect against COVID-19 with just one shot of the dose.
Key points:
- Johnson & Johnson says trial results show its one-shot vaccine is 66 per cent effective against COVID-19
- While promising, it is still behind many rivals who are using a two-shot vaccine
- The company says trying to create a vaccine which requires one shot is worthwhile as the virus continues to spread
The single-shot option is not as strong as some of its two-shot rivals, however…
Continue Reading
-
General14 hours agoLiberals go back to basics after crawling to year’s end
-
Business19 hours ago3 of the best ASX ETFs to build significant wealth
-
General19 hours agoTrolls stole Dr Juliet Turner’s joy and in doing so took their own
-
General16 hours agoProtecting victims of explicit AI content online